Trademark: 97347406
Word
COMPLEGENT
Status
Registered
Status Code
700
Status Date
Tuesday, July 25, 2023
Serial Number
97347406
Registration Number
7118859
Registration Date
Tuesday, July 25, 2023
Mark Type
4000
Filing Date
Tuesday, April 5, 2022
Published for Opposition
Tuesday, May 9, 2023

Trademark Owner History
Kyowa Kirin Co., Ltd. - Original Registrant

Classifications
5 Host cells for medical or clinical use; cells for medical use, namely, cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; cells for medical use, namely, transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; Pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors being pharmaceutical products for treatment of blood pressure, agents for the treatment of asthma, antitussives and expectorants, stomachics and digestives for pharmaceutical purposes, antacids; hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis; corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, Crohn's disease, and chronic active hepatitis; estrogen and progesterone preparations used as combined oral contraceptives; urinary antiseptics, analgesics, anti-itching agents; cataplasms for the treatment of bruises, lumbago and stiff shoulder; pharmaceutical preparations used to treat hair disorders; vitamin preparations; food enriching agents, namely, vitamin supplements, for treating vitamin deficiencies; anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa rolls and sticks for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs; germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and agricultural use; antiseptics, drugs for treating arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for pharmaceutical in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, drugs for treating Parkinson's disease; pharmaceuticals, namely, minor tranquilizers, and anti anxiety agents; pharmaceuticals, namely, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system; pharmaceuticals, namely, anti-bacterial preparations in the nature of antibacterial substances for medical purposes, monolithic preparations in the nature of substances for medical purposes, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations in the nature of radioactive substances, nutritive substances for microorganisms for medical purposes, pharmaceutical preparations for improving the metabolism and the peripheral circulation, blood plasma in the nature of plasma substitutes and extracorporeal circulation flow improvement preparations; diuretic and anti-hypertensive preparations; in vitro diagnostic reagents for medical use; in vitro extra corporeal diagnostic reagents for medical use; in vitro x-ray contrast agents for medical use; in vitro diagnostic media for medical use, and pharmaceutical preparations for the treatment of insomnia and other sleep related diseases

Trademark Events
Jul 25, 2023
Notice Of Registration Confirmation Emailed
Jul 25, 2023
Registered-Principal Register
May 9, 2023
Official Gazette Publication Confirmation E-Mailed
May 9, 2023
Published For Opposition
Apr 19, 2023
Notification Of Notice Of Publication E-Mailed
Apr 5, 2023
Electronic Record Review Complete
Mar 31, 2023
On Hold - Electronic Record Review Required
Mar 25, 2023
Approved For Pub - Principal Register
Mar 24, 2023
Teas/Email Correspondence Entered
Mar 23, 2023
Correspondence Received In Law Office
Mar 23, 2023
Teas Response To Office Action Received
Feb 14, 2023
Notification Of Non-Final Action E-Mailed
Feb 14, 2023
Non-Final Action E-Mailed
Feb 14, 2023
Non-Final Action Written
Dec 29, 2022
Assigned To Examiner
Apr 25, 2022
Preliminary/Voluntary Amendment - Entered
Apr 21, 2022
Assigned To Lie
Apr 18, 2022
Teas Voluntary Amendment Received
Apr 11, 2022
New Application Office Supplied Data Entered
Apr 8, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24